[ad_1]
Another hope! M. Oxford reveals 70% protection against COVID-19 vaccine
BBC website A November 23 report stated that the results of the COVID-19 vaccine trial Developed by the University of Oxford can effectively prevent infection at a rate of 70 percent, although it is a high rate. But even less than the efficacy of the COVID-19 vaccine. Powered by Pfizer and Modena up to 95 percent
Click read Pfizeran repeats the COVID-19 vaccine with 94% effectiveness
Click read The modern Navo vaccine against COVID is 94.5% effective.
The report states that the University of Oxford vaccine Although they are 70 percent effective, they are cheaper. Easier to stock AND easier to transport than the other two vaccines and of course the Oxford vaccine. It will continue to play a role in resolving the epidemic crisis. The British government has already ordered 100 million doses of the Oxford vaccine that can be injected into up to 50 million people.
The report indicates the results of the Oxford vaccine trial. Carried out with a total of 20,000 volunteers in the UK and Brazil. The test results showed people infected with COVID-19. After receiving 2 vaccinations, 30 people and someone infected with COVID-19. After 101 sham vaccines, the researchers said the vaccine’s protective efficacy was 70 percent.
Currently, the Oxford vaccine is being produced in 95 million doses, but regulators must approve it after a safety and efficacy evaluation. Including production standards that must be up to par. To start in the next few weeks. After that, a large vaccination program will be implemented. By the first group of people vaccinated Older people and staff in nursing homes Followed by health workers AND people older than 85 years
[ad_2]
